Editor's Choice – 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Tóm tắt
Từ khóa
Tài liệu tham khảo
Fowkes, 2013, Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis, Lancet, 382, 1329, 10.1016/S0140-6736(13)61249-0
Belcaro, 2001, Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study), Atherosclerosis, 156, 379, 10.1016/S0021-9150(00)00665-1
Giannopoulos, 2015, Long-term mortality in patients with asymptomatic carotid stenosis: implications for statin therapy, Eur J Vasc Endovasc Surg, 50, 573, 10.1016/j.ejvs.2015.06.115
Criqui, 2015, Epidemiology of peripheral artery disease, Circ Res, 116, 1509, 10.1161/CIRCRESAHA.116.303849
Fowkes, 2008, Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis, JAMA, 300, 197, 10.1001/jama.300.2.197
Weitz, 1996, Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review, Circulation, 94, 3026, 10.1161/01.CIR.94.11.3026
Valentine, 2004, Family history is a major determinant of subclinical peripheral arterial disease in young adults, J Vasc Surg, 39, 351, 10.1016/j.jvs.2003.07.011
Wassel, 2011, Family history of peripheral artery disease is associated with prevalence and severity of peripheral artery disease: the San Diego population study, J Am Coll Cardiol, 58, 1386, 10.1016/j.jacc.2011.06.023
Khaleghi, 2014, Family history as a risk factor for peripheral arterial disease, Am J Cardiol, 114, 928, 10.1016/j.amjcard.2014.06.029
Craig, 2003, International physical activity questionnaire: 12-country reliability and validity, Med Sci Sports Exerc, 35, 1381, 10.1249/01.MSS.0000078924.61453.FB
Washburn, 1993, The Physical Activity Scale for the Elderly (PASE): development and evaluation, J Clin Epidemiol, 46, 153, 10.1016/0895-4356(93)90053-4
Pickett, 2008, Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: a meta-analysis, Lancet, 371, 1587, 10.1016/S0140-6736(08)60691-1
Clark, 2012, Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis, Lancet, 379, 905, 10.1016/S0140-6736(11)61710-8
Cournot, 2009, Additional prognostic value of physical examination, exercise testing, and arterial ultrasonography for coronary risk assessment in primary prevention, Am Heart J, 158, 845, 10.1016/j.ahj.2009.08.017
Criqui, 2010, The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis), J Am Coll Cardiol, 56, 1506, 10.1016/j.jacc.2010.04.060
Wu, 2013, The effectiveness of N-acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a meta-analysis of randomized controlled trials, Int Urol Nephrol, 45, 1309, 10.1007/s11255-012-0363-1
O'Sullivan, 2013, The role of N-acetylcysteine in the prevention of contrast-induced nephropathy in patients undergoing peripheral angiography: a structured review and meta-analysis, Angiology, 64, 576, 10.1177/0003319712467223
Merten, 2004, Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial, JAMA, 291, 2328, 10.1001/jama.291.19.2328
Akyuz, 2015, The role of statins in preventing contrast-induced acute kidney injury: a narrative review, Angiology, 66, 701, 10.1177/0003319714549556
Ramalho, 2016, Gadolinium-based contrast agent accumulation and toxicity: an update, AJNR Am J Neuroradiol, 37, 1192, 10.3174/ajnr.A4615
Bullen, 2008, Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease, Expert Rev Cardiovasc Ther, 6, 883, 10.1586/14779072.6.6.883
Lim, 2012, A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet, 380, 2224, 10.1016/S0140-6736(12)61766-8
Morris, 2015, Cardiovascular effects of exposure to cigarette smoke and electronic cigarettes: clinical perspectives from the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology, J Am Coll Cardiol, 66, 1378, 10.1016/j.jacc.2015.07.037
Aung, 2007, Lipid-lowering for peripheral arterial disease of the lower limb, Cochrane Database Syst Rev, 4
Antoniou, 2014, Statin therapy in lower limb peripheral arterial disease: systematic review and meta-analysis, Vascul Pharmacol, 63, 79, 10.1016/j.vph.2014.09.001
Heart Protection Study Collaborative Group, 2007, Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions, J Vasc Surg, 45, 645, 10.1016/j.jvs.2006.12.054
Kumbhani, 2014, Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry, Eur Heart J, 35, 2864, 10.1093/eurheartj/ehu080
Westin, 2014, Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia, J Am Coll Cardiol, 63, 682, 10.1016/j.jacc.2013.09.073
Murphy, 2016, Reduction in total cardiovascular events with ezetimibe/simvastatin post-acute coronary syndrome: the IMPROVE-IT Trial, J Am Coll Cardiol, 67, 353, 10.1016/j.jacc.2015.10.077
Meade, 2002, Bezafibrate in men with lower extremity arterial disease: randomised controlled trial, BMJ, 325, 1139, 10.1136/bmj.325.7373.1139
Amarenco, 2004, Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis, Stroke, 35, 2902, 10.1161/01.STR.0000147965.52712.fa
Huang, 2013, Effect of statin therapy on the progression of common carotid artery intima-media thickness: an updated systematic review and meta-analysis of randomized controlled trials, J Atheroscler Thromb, 20, 108, 10.5551/jat.14001
Sabatine, 2017, Evolocumab and clinical outcomes in patients with cardiovascular disease, N Engl J Med, 376, 1713, 10.1056/NEJMoa1615664
Staessen, 1998, Treatment of isolated systolic hypertension in the elderly: further evidence from the systolic hypertension in Europe (Syst-Eur) trial, Am J Cardiol, 82, 20R, 10.1016/S0002-9149(98)00752-8
Mancia, 2013, 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), J Hypertens, 31, 1281, 10.1097/01.hjh.0000431740.32696.cc
Bavry, 2010, Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy, Hypertension, 55, 48, 10.1161/HYPERTENSIONAHA.109.142240
Wright, 2015, A randomized trial of intensive versus standard blood-pressure control, N Engl J Med, 373, 2103, 10.1056/NEJMoa1511939
Cushman, 2016, SPRINT trial results: latest news in hypertension management, Hypertension, 67, 263, 10.1161/HYPERTENSIONAHA.115.06722
World Health Organization, 2012
Yusuf, 2000, Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators, N Engl J Med, 342, 145, 10.1056/NEJM200001203420301
Yusuf, 2008, Telmisartan, ramipril, or both in patients at high risk for vascular events, N Engl J Med, 358, 1547, 10.1056/NEJMoa0801317
Armstrong, 2015, Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia, Vasc Med, 20, 237, 10.1177/1358863X15574321
Paravastu, 2013, Beta blockers for peripheral arterial disease, Cochrane Database Syst Rev, 9
Aronow, 2001, Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease, Am J Cardiol, 87, 1284, 10.1016/S0002-9149(01)01521-1
CAPRIE Steering Committee, 1996, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3
Law, 2009, Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies, BMJ, 338, b1665, 10.1136/bmj.b1665
Ostergren, 2004, Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease, Eur Heart J, 25, 17, 10.1016/j.ehj.2003.10.033
2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71
Sacco, 2008, Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke, N Engl J Med, 359, 1238, 10.1056/NEJMoa0805002
Bhatt, 2007, Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial, J Am Coll Cardiol, 49, 1982, 10.1016/j.jacc.2007.03.025
Markus, 2005, Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial, Circulation, 111, 2233, 10.1161/01.CIR.0000163561.90680.1C
Wang, 2013, Clopidogrel with aspirin in acute minor stroke or transient ischemic attack, N Engl J Med, 369, 11, 10.1056/NEJMoa1215340
Dalainas, 2006, Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting, Cardiovasc Intervent Radiol, 29, 519, 10.1007/s00270-005-5288-y
McKevitt, 2005, The benefits of combined anti-platelet treatment in carotid artery stenting, Eur J Vasc Endovasc Surg, 29, 522, 10.1016/j.ejvs.2005.01.012
Gensicke, 2015, Ischemic brain lesions after carotid artery stenting increase future cerebrovascular risk, J Am Coll Cardiol, 65, 521, 10.1016/j.jacc.2014.11.038
Udell, 2016, Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials, Eur Heart J, 37, 390
Schmit, 2014, Comparative effectiveness review of antiplatelet agents in peripheral artery disease, J Am Heart Assoc, 3, e001330, 10.1161/JAHA.113.001330
Belch, 2010, Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial, J Vasc Surg, 52, 825, 10.1016/j.jvs.2010.04.027
Cacoub, 2009, Patients with peripheral arterial disease in the CHARISMA trial, Eur Heart J, 30, 192, 10.1093/eurheartj/ehn534
Fowkes, 2010, Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial, JAMA, 303, 841, 10.1001/jama.2010.221
Belch, 2008, The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease, BMJ, 337, a1840, 10.1136/bmj.a1840
Berger, 2009, Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials, JAMA, 301, 1909, 10.1001/jama.2009.623
Hiatt, 2017, Ticagrelor versus clopidogrel in symptomatic peripheral artery disease, N Engl J Med, 376, 32, 10.1056/NEJMoa1611688
Bonaca, 2013, Vorapaxar in patients with peripheral artery disease: results from TRA2°P-TIMI 50, Circulation, 127, 1522, 10.1161/CIRCULATIONAHA.112.000679
Bedenis, 2015, Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery, Cochrane Database Syst Rev, 2
2000, Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial, Lancet, 355, 346, 10.1016/S0140-6736(99)07199-8
Johnson, 2002, Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study, J Vasc Surg, 35, 413, 10.1067/mva.2002.121847
Monaco, 2012, Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients, J Vasc Surg, 56, 96, 10.1016/j.jvs.2012.01.004
Dake, 2016, Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial, Circulation, 133, 1472, 10.1161/CIRCULATIONAHA.115.016900
Laird, 2015, Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA, J Am Coll Cardiol, 66, 2329, 10.1016/j.jacc.2015.09.063
Dagher, 2007, Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins, Semin Vasc Surg, 20, 10, 10.1053/j.semvascsurg.2007.02.006
Franzone, 2016, Prolonged vs short duration of dual antiplatelet therapy after percutaneous coronary intervention in patients with or without peripheral arterial disease: a subgroup analysis of the PRODIGY randomized clinical trial, JAMA Cardiol, 1, 795, 10.1001/jamacardio.2016.2811
Bonaca, 2015, Long-term use of ticagrelor in patients with prior myocardial infarction, N Engl J Med, 372, 1791, 10.1056/NEJMoa1500857
Bonaca, 2016, Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease, J Am Coll Cardiol, 67, 2719, 10.1016/j.jacc.2016.03.524
2017 Guidelines for DAPT (citation pending).
Kirchhof, 2016, 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Eur Heart J, 37, 2893, 10.1093/eurheartj/ehw210
Winkel, 2010, Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry, Eur J Vasc Endovasc Surg, 40, 9, 10.1016/j.ejvs.2010.03.003
Jones, 2014, Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF, Eur Heart J, 35, 242, 10.1093/eurheartj/eht492
Heidbuchel, 2015, Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation, Europace, 17, 1467, 10.1093/europace/euv309
Baigent, 2009, Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, Lancet, 373, 1849, 10.1016/S0140-6736(09)60503-1
Donaldson, 1985, The influence of platelet inhibition on the patency of femoro-popliteal Dacron bypass grafts, Vasc Endovasc Surg, 19, 224
McCollum, 1991, Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial, J Vasc Surg, 13, 150, 10.1016/0741-5214(91)90022-M
Hart, 2007, Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation, Ann Intern Med, 146, 857, 10.7326/0003-4819-146-12-200706190-00007
Lamberts, 2014, Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: a nationwide cohort study, J Am Coll Cardiol, 63, 2689, 10.1016/j.jacc.2014.03.039
Sacco, 2013, An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, 44, 2064, 10.1161/STR.0b013e318296aeca
Sprynger M, RF, Moonen M, Aboyans V, Edvardsen T, Alcantara M, et al. EACVI recommendations on echovascular imaging assessment of arterial diseases: Partim I, 2017 [in preparation].
Esposito-Bauer, 2013, MRI plaque imaging detects carotid plaques with a high risk for future cerebrovascular events in asymptomatic patients, PLoS One, 8, e67927, 10.1371/journal.pone.0067927
Gupta, 2015, Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis, Stroke, 46, 91, 10.1161/STROKEAHA.114.006091
Naylor, 2014, Clinical and imaging features associated with an increased risk of late stroke in patients with asymptomatic carotid disease, Eur J Vasc Endovasc Surg, 48, 633, 10.1016/j.ejvs.2014.08.017
Sloan, 2004, Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Neurology, 62, 1468, 10.1212/WNL.62.9.1468
Wardlaw, 2006, Accurate, practical and cost-effective assessment of carotid stenosis in the UK, Health Technol Assess, 10, 10.3310/hta10300
Blackshear, 2011, Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial, Circulation, 123, 2571, 10.1161/CIRCULATIONAHA.110.008250
Giannakopoulos, 2012, Association between plaque echogenicity and embolic material captured in filter during protected carotid angioplasty and stenting, Eur J Vasc Endovasc Surg, 43627
Akkaya, 2014, Cerebral microemboli and neurocognitive change after carotid artery stenting with different embolic protection devices, Int J Cardiol, 176, 478, 10.1016/j.ijcard.2014.07.241
Bijuklic, 2012, The PROFI study (Prevention of Cerebral Embolization by Proximal Balloon Occlusion Compared to Filter Protection During Carotid Artery Stenting): a prospective randomized trial, J Am Coll Cardiol, 59, 1383, 10.1016/j.jacc.2011.11.035
Cano, 2013, Randomized comparison of distal and proximal cerebral protection during carotid artery stenting, JACC Cardiovasc Interv, 6, 1203, 10.1016/j.jcin.2013.07.006
Montorsi, 2011, Microembolization during carotid artery stenting in patients with high-risk, lipid-rich plaque. A randomized trial of proximal versus distal cerebral protection, J Am Coll Cardiol, 58, 1656, 10.1016/j.jacc.2011.07.015
Stabile, 2013, Operator's experience is the most efficient embolic protection device for carotid artery stenting, Circ Cardiovasc Interv, 6, 496, 10.1161/CIRCINTERVENTIONS.113.000814
Garg, 2009, Cerebral protection devices reduce periprocedural strokes during carotid angioplasty and stenting: a systematic review of the current literature, J Endovasc Ther, 16, 412, 10.1583/09-2713.1
Touze, 2009, Systematic review of the perioperative risks of stroke or death after carotid angioplasty and stenting, Stroke, 40, e683, 10.1161/STROKEAHA.109.562041
Zahn, 2007, Carotid artery stenting in octogenarians: results from the ALKK Carotid Artery Stent (CAS) Registry, Eur Heart J, 28, 370, 10.1093/eurheartj/ehl421
Rosenfield, 2016, Randomized trial of stent versus surgery for asymptomatic carotid stenosis, N Engl J Med, 374, 1011, 10.1056/NEJMoa1515706
Jansen, 2009, Protection or nonprotection in carotid stent angioplasty: the influence of interventional techniques on outcome data from the SPACE Trial, Stroke, 40, 841, 10.1161/STROKEAHA.108.534289
Gray, 2011, Influence of site and operator characteristics on carotid artery stent outcomes: analysis of the CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events) clinical study, JACC Cardiovasc Interv, 4, 235, 10.1016/j.jcin.2010.10.009
Nallamothu, 2011, Operator experience and carotid stenting outcomes in Medicare beneficiaries, JAMA, 306, 1338, 10.1001/jama.2011.1357
1995, Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study, JAMA, 273, 1421, 10.1001/jama.1995.03520420037035
Halliday, 2010, 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial, Lancet, 376, 1074, 10.1016/S0140-6736(10)61197-X
Halliday, 2004, Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial, Lancet, 363, 1491, 10.1016/S0140-6736(04)16146-1
Rothwell, 2004, Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke, Stroke, 35, 2855, 10.1161/01.STR.0000147040.20446.f6
Hadar, 2014, Asymptomatic carotid artery stenosis treated with medical therapy alone: temporal trends and implications for risk assessment and the design of future studies, Cerebrovasc Dis, 38, 163, 10.1159/000365206
Naylor, 2009, Who benefits most from intervention for asymptomatic carotid stenosis: patients or professionals?, Eur J Vasc Endovasc Surg, 37, 625, 10.1016/j.ejvs.2009.01.026
Baker, 2000, Effect of contralateral occlusion on long-term efficacy of endarterectomy in the Asymptomatic Carotid Atherosclerosis Study (ACAS). ACAS Investigators, Stroke, 31, 2330, 10.1161/01.STR.31.10.2330
Nicolaides, 2005, Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: results from the ACSRS study, Eur J Vasc Endovasc Surg, 30, 275, 10.1016/j.ejvs.2005.04.031
Kakkos, 2009, Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery stenosis, J Vasc Surg, 49, 902, 10.1016/j.jvs.2008.10.059
Kakkos, 2014, Predictors and clinical significance of progression or regression of asymptomatic carotid stenosis, J Vasc Surg, 59, 956, 10.1016/j.jvs.2013.10.073
Markus, 2010, Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study, Lancet Neurol, 9, 663, 10.1016/S1474-4422(10)70120-4
King, 2011, Does impaired cerebrovascular reactivity predict stroke risk in asymptomatic carotid stenosis? A prospective substudy of the asymptomatic carotid emboli study, Stroke, 42, 1550, 10.1161/STROKEAHA.110.609057
Nicolaides, 2010, Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification, J Vasc Surg, 52, 1486, 10.1016/j.jvs.2010.07.021
Kakkos, 2013, The size of juxtaluminal hypoechoic area in ultrasound images of asymptomatic carotid plaques predicts the occurrence of stroke, J Vasc Surg, 57, 609, 10.1016/j.jvs.2012.09.045
Gupta, 2013, Carotid plaque MRI and stroke risk: a systematic review and meta-analysis, Stroke, 44, 3071, 10.1161/STROKEAHA.113.002551
Hawkins, 2015, Hospital variation in carotid stenting outcomes, JACC Cardiovasc Interv, 6, 858, 10.1016/j.jcin.2015.01.026
Kallmayer, 2015, Patient characteristics and outcomes of carotid endarterectomy and carotid artery stenting: analysis of the German mandatory national quality assurance registry – 2003 to 2014, J Cardiovasc Surg (Torino), 56, 827
Werner, 2015, Fifteen-year experience with carotid artery stenting (from the carotid artery stenting-registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte), Am J Cardiol, 115, 360, 10.1016/j.amjcard.2014.11.009
Paraskevas, 2016, Stroke/death rates following carotid artery stenting and carotid endarterectomy in contemporary administrative dataset registries: a systematic review, Eur J Vasc Endovasc Surg, 51, 3, 10.1016/j.ejvs.2015.07.032
Choi, 2015, Early outcomes after carotid artery stenting compared with endarterectomy for asymptomatic carotid stenosis, Stroke, 46, 120, 10.1161/STROKEAHA.114.006209
Dua, 2016, Predictors of poor outcome after carotid intervention, J Vasc Surg, 64, 663, 10.1016/j.jvs.2016.03.428
Yadav, 2004, Protected carotid-artery stenting versus endarterectomy in high-risk patients, N Engl J Med, 351, 1493, 10.1056/NEJMoa040127
Gurm, 2008, Long-term results of carotid stenting versus endarterectomy in high-risk patients, N Engl J Med, 358, 1572, 10.1056/NEJMoa0708028
Silver, 2011, Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST), Stroke, 42, 675, 10.1161/STROKEAHA.110.610212
Rothwell, 2003, Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis, Lancet, 361, 107, 10.1016/S0140-6736(03)12228-3
Naylor, 2015, Clinical and imaging features associated with an increased risk of early and late stroke in patients with symptomatic carotid disease, Eur J Vasc Endovasc Surg, 49, 513, 10.1016/j.ejvs.2015.01.011
Stromberg, 2012, Very urgent carotid endarterectomy confers increased procedural risk, Stroke, 43, 1331, 10.1161/STROKEAHA.111.639344
Loftus, 2016, Delays to surgery and procedural risks following carotid endarterectomy in the UK National Vascular Registry, Eur J Vasc Endovasc Surg, 52, 438, 10.1016/j.ejvs.2016.05.031
Tsantilas, 2016, Short time interval between neurologic event and carotid surgery is not associated with an increased procedural risk, Stroke, 47, 2783, 10.1161/STROKEAHA.116.014058
Bush, 2016, Endovascular treatment with stent-retriever devices for acute ischemic stroke: a meta-analysis of randomized controlled trials, PLoS One, 11, e0147287, 10.1371/journal.pone.0147287
Berkhemer, 2015, A randomized trial of intraarterial treatment for acute ischemic stroke, N Engl J Med, 372, 11, 10.1056/NEJMoa1411587
Brott, 2010, Stenting versus endarterectomy for treatment of carotid-artery stenosis, N Engl J Med, 363, 11, 10.1056/NEJMoa0912321
Hill, 2012, Stroke after carotid stenting and endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST), Circulation, 126, 3054, 10.1161/CIRCULATIONAHA.112.120030
Economopoulos, 2011, Carotid artery stenting versus carotid endarterectomy: a comprehensive meta-analysis of short-term and long-term outcomes, Stroke, 42, 687, 10.1161/STROKEAHA.110.606079
Bonati, 2012, Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis, Cochrane Database Syst Rev, 9
Rantner, 2013, The risk of carotid artery stenting compared with carotid endarterectomy is greatest in patients treated within 7 days of symptoms, J Vasc Surg, 57, 619, 10.1016/j.jvs.2012.08.107
Meschia, 2015, Time from symptoms to carotid endarterectomy or stenting and perioperative risk, Stroke, 46, 3540, 10.1161/STROKEAHA.115.011123
Howard, 2016, Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: a meta-analysis of pooled patient data from four randomised trials, Lancet, 387, 1305, 10.1016/S0140-6736(15)01309-4
Bonati, 2015, Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trial, Lancet, 385, 529, 10.1016/S0140-6736(14)61184-3
Brott, 2016, Long-term results of stenting versus endarterectomy for carotid-artery stenosis, N Engl J Med, 374, 1021, 10.1056/NEJMoa1505215
1998, Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST), Lancet, 351, 1379, 10.1016/S0140-6736(97)09292-1
Barnett, 1998, Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators, N Engl J Med, 339, 1415, 10.1056/NEJM199811123392002
Borhani Haghighi, 2011, Vertebral artery origin stenosis and its treatment, J Stroke Cerebrovasc Dis, 20, 369, 10.1016/j.jstrokecerebrovasdis.2011.05.007
Khan, 2007, Imaging of vertebral artery stenosis: a systematic review, J Neurol Neurosurg Psychiatry, 78, 1218, 10.1136/jnnp.2006.111716
Kumar Dundamadappa, 2013, Vertebral artery ostial stenosis: prevalence by digital subtraction angiography, MR angiography, and CT angiography, J Neuroimaging, 23, 360, 10.1111/j.1552-6569.2011.00692.x
Berguer, 2000, Surgical reconstruction of the extracranial vertebral artery: management and outcome, J Vasc Surg, 31, 9, 10.1016/S0741-5214(00)70063-2
Kieffer, 2002, Distal vertebral artery reconstruction: long-term outcome, J Vasc Surg, 36, 549, 10.1067/mva.2002.126092
Stayman, 2011, A systematic review of stenting and angioplasty of symptomatic extracranial vertebral artery stenosis, Stroke, 42, 2212, 10.1161/STROKEAHA.110.611459
Compter, 2015, Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial, Lancet Neurol, 14, 606, 10.1016/S1474-4422(15)00017-4
Aboyans, 2007, The vital prognosis of subclavian stenosis, J Am Coll Cardiol, 49, 1540, 10.1016/j.jacc.2006.09.055
Klitfod, 2014, Treatment of chronic upper limb ischaemia is safe and results are good, Dan Med J, 61, A4859
Daniel, 2014, Contemporary comparison of supra-aortic trunk surgical reconstructions for occlusive disease, J Vasc Surg, 59, 1577, 10.1016/j.jvs.2013.12.017
Duran, 2015, Subclavian carotid transposition: immediate and long-term outcomes of 126 surgical reconstructions, Ann Vasc Surg, 29, 397, 10.1016/j.avsg.2014.09.030
Burihan, 2011, Angioplasty versus stenting for subclavian artery stenosis, Cochrane Database Syst Rev, 10, 10.1002/14651858.CD008461.pub2
Chatterjee, 2013, Angioplasty alone versus angioplasty and stenting for subclavian artery stenosis—a systematic review and meta-analysis, Am J Ther, 20, 520, 10.1097/MJT.0b013e31822831d8
Huttl, 2002, Angioplasty of the innominate artery in 89 patients: experience over 19 years, Cardiovasc Intervent Radiol, 25, 109, 10.1007/s00270-001-0074-y
van de Weijer, 2015, Technical and clinical success and long-term durability of endovascular treatment for atherosclerotic aortic arch branch origin obstruction: evaluation of 144 procedures, Eur J Vasc Endovasc Surg, 50, 13, 10.1016/j.ejvs.2015.03.058
Modarai, 2004, Comparison of extra-anatomic bypass grafting with angioplasty for atherosclerotic disease of the supra-aortic trunks, Br J Surg, 91, 1453, 10.1002/bjs.4751
Owens, 1995, Extrathoracic reconstruction of arterial occlusive disease involving the supraaortic trunks, J Vasc Surg, 22, 217, 10.1016/S0741-5214(95)70133-8
Song, 2012, Endovascular stenting vs. extrathoracic surgical bypass for symptomatic subclavian steal syndrome, J Endovasc Ther, 19, 44, 10.1583/11-3692.1
Lee, 2006, A 7-year experience with thoracoscopic sympathectomy for critical upper limb ischemia, World J Surg, 30, 1644, 10.1007/s00268-005-0559-y
Björck, 2017, Management of the diseases of mesenteric arteries and veins: clinical practice guidelines of the European Society of Vascular Surgery (ESVS), Eur J Vasc Endovasc Surg, 53, 460, 10.1016/j.ejvs.2017.01.010
Acosta, 2004, D-dimer testing in patients with suspected acute thromboembolic occlusion of the superior mesenteric artery, Br J Surg, 91, 991, 10.1002/bjs.4645
Block, 2008, Diagnostic accuracy of plasma biomarkers for intestinal ischaemia, Scand J Clin Lab Invest, 68, 242, 10.1080/00365510701646264
Matsumoto, 2014, Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia, Br J Surg, 101, 232, 10.1002/bjs.9331
Cudnik, 2013, The diagnosis of acute mesenteric ischemia: a systematic review and meta-analysis, Acad Emerg Med, 20, 1087, 10.1111/acem.12254
Lehtimaki, 2015, Detecting acute mesenteric ischemia in CT of the acute abdomen is dependent on clinical suspicion: review of 95 consecutive patients, Eur J Radiol, 84, 2444, 10.1016/j.ejrad.2015.09.006
Jrvinen, 1994, Acute intestinal ischaemia. A review of 214 cases, Ann Chir Gynaecol, 83, 22
Beaulieu, 2014, Comparison of open and endovascular treatment of acute mesenteric ischemia, J Vasc Surg, 59, 159, 10.1016/j.jvs.2013.06.084
Bjorck, 2015, Debate: Whether an endovascular-first strategy is the optimal approach for treating acute mesenteric ischemia, J Vasc Surg, 62, 767, 10.1016/j.jvs.2015.04.431
Block, 2010, Endovascular and open surgery for acute occlusion of the superior mesenteric artery, J Vasc Surg, 52, 959, 10.1016/j.jvs.2010.05.084
Kalra, 2012, Contemporary results of treatment of acute arterial mesenteric thrombosis: has endovascular treatment improved outcomes?, Perspect Vasc Surg Endovasc Ther, 24, 171, 10.1177/1531003513490033
Wyers, 2007, Retrograde mesenteric stenting during laparotomy for acute occlusive mesenteric ischemia, J Vasc Surg, 45, 269, 10.1016/j.jvs.2006.10.047
Arthurs, 2011, A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia, J Vasc Surg, 53, 698, 10.1016/j.jvs.2010.09.049
Schermerhorn, 2009, Mesenteric revascularization: management and outcomes in the United States, 1988–2006, J Vasc Surg, 50, 341, 10.1016/j.jvs.2009.03.004
Rotondo, 1993, ‘Damage control’: an approach for improved survival in exsanguinating penetrating abdominal injury, J Trauma, 35, 375
Bjorck, 2002, Revascularization of the superior mesenteric artery after acute thromboembolic occlusion, Br J Surg, 89, 923, 10.1046/j.1365-2168.2002.02150.x
Bjornsson, 2011, Thrombolysis for acute occlusion of the superior mesenteric artery, J Vasc Surg, 54, 1734, 10.1016/j.jvs.2011.07.054
Thomas, 1998, The clinical course of asymptomatic mesenteric arterial stenosis, J Vasc Surg, 27, 840, 10.1016/S0741-5214(98)70263-0
van Petersen, 2013, The influence of respiration on criteria for transabdominal duplex examination of the splanchnic arteries in patients with suspected chronic splanchnic ischemia, J Vasc Surg, 57, 1603, 10.1016/j.jvs.2012.11.120
Zwolak, 1998, Mesenteric and celiac duplex scanning: a validation study, J Vasc Surg, 27, 1078, 10.1016/S0741-5214(98)60010-0
Rheudasil, 1988, Surgical treatment of chronic mesenteric arterial insufficiency, J Vasc Surg, 8, 495, 10.1016/0741-5214(88)90117-6
Moghadamyeghaneh, 2015, Early outcome of treatment of chronic mesenteric ischemia, Am Surg, 81, 1149, 10.1177/000313481508101128
Rawat, 2010, Surgical or endovascular treatment for chronic mesenteric ischemia: a multicenter study, Ann Vasc Surg, 24, 935, 10.1016/j.avsg.2010.05.007
Peck, 2010, Intermediate-term outcomes of endovascular treatment for symptomatic chronic mesenteric ischemia, J Vasc Surg, 51, 140, 10.1016/j.jvs.2009.06.064
Silva, 2006, Endovascular therapy for chronic mesenteric ischemia, J Am Coll Cardiol, 47, 944, 10.1016/j.jacc.2005.10.056
Malgor, 2010, Results of single- and two-vessel mesenteric artery stents for chronic mesenteric ischemia, Ann Vasc Surg, 24, 1094, 10.1016/j.avsg.2010.07.001
Oderich, 2013, Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease, J Vasc Surg, 58, 1316, 10.1016/j.jvs.2013.05.013
Menke, 2010, Thromboembolism in atrial fibrillation, Am J Cardiol, 105, 502, 10.1016/j.amjcard.2009.10.018
Mensink, 2006, Clinical significance of splanchnic artery stenosis, Br J Surg, 93, 1377, 10.1002/bjs.5481
Persu, 2014, European consensus on the diagnosis and management of fibromuscular dysplasia, J Hypertens, 32, 1367, 10.1097/HJH.0000000000000213
Messerli, 2011, Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering syndrome, Eur Heart J, 32, 2231, 10.1093/eurheartj/ehr056
Jennings, 2014, Renal artery stenosis-when to screen, what to stent?, Curr Atheroscler Rep, 16, 416, 10.1007/s11883-014-0416-2
Zeller, 2008, Color-coded duplex ultrasound for diagnosis of renal artery stenosis and as follow-up examination after revascularization, Catheter Cardiovasc Interv, 71, 995, 10.1002/ccd.21525
Williams, 2007, Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis, AJR Am J Roentgenol, 188, 798, 10.2214/AJR.06.0355
AbuRahma, 2013, Renal imaging: duplex ultrasound, computed tomography angiography, magnetic resonance angiography, and angiography, Semin Vasc Surg, 26, 134, 10.1053/j.semvascsurg.2014.06.001
Tan, 2002, Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis, Clin Radiol, 57, 617, 10.1053/crad.2002.0941
De Bruyne, 2006, Assessment of renal artery stenosis severity by pressure gradient measurements, J Am Coll Cardiol, 48, 1851, 10.1016/j.jacc.2006.05.074
Drieghe, 2008, Assessment of renal artery stenosis: side-by-side comparison of angiography and duplex ultrasound with pressure gradient measurements, Eur Heart J, 29, 517, 10.1093/eurheartj/ehm631
Conlon, 2001, Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography, Kidney Int, 60, 1490, 10.1046/j.1523-1755.2001.00953.x
Mailloux, 1994, Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: a 20-year clinical experience, Am J Kidney Dis, 24, 622, 10.1016/S0272-6386(12)80223-X
Evans, 2014, Use of renin-angiotensin inhibitors in people with renal artery stenosis, Clin J Am Soc Nephrol, 9, 1199, 10.2215/CJN.11611113
Hackam, 2008, Angiotensin inhibition in renovascular disease: a population-based cohort study, Am Heart J, 156, 549, 10.1016/j.ahj.2008.05.013
Chrysochou, 2012, Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular disease, Nephrol Dial Transplant, 27, 1403, 10.1093/ndt/gfr496
Losito, 2005, Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition, Nephrol Dial Transplant, 20, 1604, 10.1093/ndt/gfh865
Hackam, 2011, Statins and renovascular disease in the elderly: a population-based cohort study, Eur Heart J, 32, 598, 10.1093/eurheartj/ehq452
Vashist, 2002, Renal artery stenosis: a cardiovascular perspective, Am Heart J, 143, 559, 10.1067/mhj.2002.120769
Chrysant, 2014, Proper patient selection yields significant and sustained reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: long-term results from the HERCULES trial, J Clin Hypertens (Greenwich), 16, 497, 10.1111/jch.12341
Jaff, 2012, Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial, Catheter Cardiovasc Interv, 80, 343, 10.1002/ccd.24449
Nordmann, 2003, Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials, Am J Med, 114, 44, 10.1016/S0002-9343(02)01396-7
Bavry, 2014, Renal artery revascularization: updated meta-analysis with the CORAL trial, JAMA Intern Med, 174, 1849, 10.1001/jamainternmed.2014.4332
Cooper, 2014, Stenting and medical therapy for atherosclerotic renal-artery stenosis, N Engl J Med, 370, 13, 10.1056/NEJMoa1310753
Murphy, 2015, Renal artery stent outcomes: effect of baseline blood pressure, stenosis severity, and translesion pressure gradient, J Am Coll Cardiol, 66, 2487, 10.1016/j.jacc.2015.09.073
Wheatley, 2009, Revascularization versus medical therapy for renal-artery stenosis, N Engl J Med, 361, 1953, 10.1056/NEJMoa0905368
Bax, 2009, Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial, Ann Intern Med, 150, 840, 10.7326/0003-4819-150-12-200906160-00119
Olin, 2014, Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association, Circulation, 129, 1048, 10.1161/01.cir.0000442577.96802.8c
Davies, 2008, The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia, J Vasc Surg, 48, 865, 10.1016/j.jvs.2008.05.030
Mousa, 2012, Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period, J Vasc Surg, 55, 421, 10.1016/j.jvs.2011.09.006
Trinquart, 2010, Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis, Hypertension, 56, 525, 10.1161/HYPERTENSIONAHA.110.152918
Kane, 2010, Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis, Nephrol Dial Transplant, 25, 813, 10.1093/ndt/gfp393
Ritchie, 2014, High-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization, Am J Kidney Dis, 63, 186, 10.1053/j.ajkd.2013.07.020
van den Berg, 2012, The efficacy of renal angioplasty in patients with renal artery stenosis and flash oedema or congestive heart failure: a systematic review, Eur J Heart Fail, 14, 773, 10.1093/eurjhf/hfs037
Cianci, 2011, Revascularization versus medical therapy for renal artery stenosis: antihypertensive drugs and renal outcome, Angiology, 62, 92, 10.1177/0003319710371615
Abela, 2009, An analysis comparing open surgical and endovascular treatment of atherosclerotic renal artery stenosis, Eur J Vasc Endovasc Surg, 38, 666, 10.1016/j.ejvs.2009.08.002
Balzer, 2012, Renal artery revascularization after unsuccessful percutaneous therapy: a single centre experience, Langenbecks Arch Surg, 397, 111, 10.1007/s00423-011-0857-9
Balzer, 2009, Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD), J Vasc Surg, 49, 667, 10.1016/j.jvs.2008.10.006
McDermott, 2001, Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment, JAMA, 286, 1599, 10.1001/jama.286.13.1599
Leng, 1992, The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys, J Clin Epidemiol, 45, 1101, 10.1016/0895-4356(92)90150-L
Norgren, 2007, Inter-society consensus for the management of peripheral arterial disease (TASC II), J Vasc Surg, 45, S5, 10.1016/j.jvs.2006.12.037
Abou-Zamzam, 2007, A prospective analysis of critical limb ischemia: factors leading to major primary amputation versus revascularization, Ann Vasc Surg, 21, 458, 10.1016/j.avsg.2006.12.006
Abu Dabrh, 2015, The natural history of untreated severe or critical limb ischemia, J Vasc Surg, 62, 1642, 10.1016/j.jvs.2015.07.065
Sigvant, 2016, The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease, Eur J Vasc Endovasc Surg, 51, 395, 10.1016/j.ejvs.2015.10.022
Xu, 2013, Diagnostic value of ankle-brachial index in peripheral arterial disease: a meta-analysis, Can J Cardiol, 29, 492, 10.1016/j.cjca.2012.06.014
Aboyans, 2012, Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association, Circulation, 126, 2890, 10.1161/CIR.0b013e318276fbcb
Tehan, 2016, A systematic review of the sensitivity and specificity of the toe-brachial index for detecting peripheral artery disease, Vasc Med, 21, 382, 10.1177/1358863X16645854
Collins, 2007, A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease, Health Technol Assess, 11, 1, 10.3310/hta11200
Met, 2009, Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis, JAMA, 301, 415, 10.1001/jama.301.4.415
Menke, 2010, Meta-analysis: accuracy of contrast-enhanced magnetic resonance angiography for assessing steno-occlusions in peripheral arterial disease, Ann Intern Med, 153, 325, 10.7326/0003-4819-153-5-201009070-00007
Koelemay, 2001, Magnetic resonance angiography for the evaluation of lower extremity arterial disease: a meta-analysis, JAMA, 285, 1338, 10.1001/jama.285.10.1338
Ouwendijk, 2008, Multicenter randomized controlled trial of the costs and effects of noninvasive diagnostic imaging in patients with peripheral arterial disease: the DIPAD trial, AJR Am J Roentgenol, 190, 1349, 10.2214/AJR.07.3359
Barba, 2005, Detection of abdominal aortic aneurysm in patients with peripheral artery disease, Eur J Vasc Endovasc Surg, 30, 504, 10.1016/j.ejvs.2005.05.011
Giugliano, 2012, Abdominal aortic aneurysm in patients affected by intermittent claudication: prevalence and clinical predictors, BMC Surg, 12, S17, 10.1186/1471-2482-12-S1-S17
Juergens, 1960, Arteriosclerosis obliterans: review of 520 cases with special reference to pathogenic and prognostic factors, Circulation, 21, 188, 10.1161/01.CIR.21.2.188
Momsen, 2009, Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies, Eur J Vasc Endovasc Surg, 38, 463, 10.1016/j.ejvs.2009.06.002
Shahin, 2013, Meta-analysis of angiotensin converting enzyme inhibitors effect on walking ability and ankle brachial pressure index in patients with intermittent claudication, Atherosclerosis, 231, 283, 10.1016/j.atherosclerosis.2013.09.037
Vlachopoulos, 2016, Angiotensin converting enzyme inhibitors and walking distance: have we walked the whole distance?, Atherosclerosis, 252, 199, 10.1016/j.atherosclerosis.2016.08.001
Bagger, 1997, Effect of verapamil in intermittent claudication A randomized, double-blind, placebo-controlled, cross-over study after individual dose-response assessment, Circulation, 95, 411, 10.1161/01.CIR.95.2.411
Espinola-Klein, 2011, Beta-blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial, Hypertension, 58, 148, 10.1161/HYPERTENSIONAHA.110.169169
Soga, 2015, Beta-blocker treatment does not worsen critical limb ischemia in patients receiving endovascular therapy, J Atheroscler Thromb, 22, 481, 10.5551/jat.27359
Mirault, 2017, Impact of beta-blockers on general and local outcome in patients hospitalized for lower extremity peripheral artery disease. The COPART Registry, Medicine (Baltimore), 96, e5916, 10.1097/MD.0000000000005916
Lane, 2014, Exercise for intermittent claudication, Cochrane Database Syst Rev, 7
Fokkenrood, 2013, Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication, Cochrane Database Syst Rev, 8
Gommans, 2015, Safety of supervised exercise therapy in patients with intermittent claudication, J Vasc Surg, 61, 512, 10.1016/j.jvs.2014.08.070
Bermingham, 2013, The cost-effectiveness of supervised exercise for the treatment of intermittent claudication, Eur J Vasc Endovasc Surg, 46, 707, 10.1016/j.ejvs.2013.09.005
Al-Jundi, 2013, Systematic review of home-based exercise programmes for individuals with intermittent claudication, Eur J Vasc Endovasc Surg, 46, 690, 10.1016/j.ejvs.2013.09.004
Back, 2015, Home-based supervised exercise versus hospital-based supervised exercise or unsupervised walk advice as treatment for intermittent claudication: a systematic review, J Rehabil Med, 47, 801, 10.2340/16501977-2012
Lauret, 2014, Modes of exercise training for intermittent claudication, Cochrane Database Syst Rev, 7
Jakubseviciene, 2014, Effectiveness of a new exercise program after lower limb arterial blood flow surgery in patients with peripheral arterial disease: a randomized clinical trial, Int J Environ Res Public Health, 11, 7961, 10.3390/ijerph110807961
Kruidenier, 2011, Additional supervised exercise therapy after a percutaneous vascular intervention for peripheral arterial disease: a randomized clinical trial, J Vasc Interv Radiol, 22, 961, 10.1016/j.jvir.2011.02.017
Gargiulo, 2012, Use of statins in lower extremity artery disease: a review, BMC Surg, 12, S15, 10.1186/1471-2482-12-S1-S15
McDermott, 2003, Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease, Circulation, 107, 757, 10.1161/01.CIR.0000050380.64025.07
Robertson, 2013, Prostanoids for intermittent claudication, Cochrane Database Syst Rev, 4
Stevens, 2012, Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication, Br J Surg, 99, 1630, 10.1002/bjs.8895
Indes, 2013, Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis, J Endovasc Ther, 20, 443, 10.1583/13-4242.1
Grimme, 2015, Editor's choice—first results of the covered endovascular reconstruction of the aortic bifurcation (CERAB) technique for aortoiliac occlusive disease, Eur J Vasc Endovasc Surg, 50, 638, 10.1016/j.ejvs.2015.06.112
Anderson, 2014, Clinical practice guidelines on perioperative cardiovascular evaluation: collaborative efforts among the ACC, AHA, and ESC, Circulation, 130, 2213, 10.1161/CIR.0000000000000103
Klinkert, 2004, Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature, Eur J Vasc Endovasc Surg, 27, 357, 10.1016/j.ejvs.2003.12.027
Malgor, 2015, A systematic review of treatment of intermittent claudication in the lower extremities, J Vasc Surg, 61, 54s, 10.1016/j.jvs.2014.12.007
Murphy, 2012, Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) study, Circulation, 125, 130, 10.1161/CIRCULATIONAHA.111.075770
Bendermacher, 2006, Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication, Cochrane Database Syst Rev, 2, 10.1002/14651858.CD005263.pub2
Fakhry, 2015, Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial, JAMA, 314, 1936, 10.1001/jama.2015.14851
Vemulapalli, 2015, Supervised vs unsupervised exercise for intermittent claudication: a systematic review and meta-analysis, Am Heart J, 169, 924, 10.1016/j.ahj.2015.03.009
Jongkind, 2010, A systematic review of endovascular treatment of extensive aortoiliac occlusive disease, J Vasc Surg, 52, 1376, 10.1016/j.jvs.2010.04.080
Ballotta, 2012, Reconstructive surgery for complex aortoiliac occlusive disease in young adults, J Vasc Surg, 56, 1606, 10.1016/j.jvs.2012.05.105
Bredahl, 2015, Mortality and complications after aortic bifurcated bypass procedures for chronic aortoiliac occlusive disease, J Vasc Surg, 62, 75, 10.1016/j.jvs.2015.02.025
Bosiers, 2013, BRAVISSIMO: 12-month results from a large scale prospective trial, J Cardiovasc Surg (Torino), 54, 235
Ye, 2011, Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions, J Vasc Surg, 53, 1728, 10.1016/j.jvs.2011.02.005
Goode, 2013, Randomized clinical trial of stents versus angioplasty for the treatment of iliac artery occlusions (STAG trial), Br J Surg, 100, 1148, 10.1002/bjs.9197
Antoniou, 2009, Hybrid endovascular and open treatment of severe multilevel lower extremity arterial disease, Eur J Vasc Endovasc Surg, 38, 616, 10.1016/j.ejvs.2009.06.016
Dosluoglu, 2010, Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease, J Vasc Surg, 51, 1425, 10.1016/j.jvs.2010.01.092
Kavanagh, 2016, Hybrid external iliac selective endarterectomy surgical technique and outcomes, J Vasc Surg, 64, 1327, 10.1016/j.jvs.2016.03.468
Matsagkas, 2011, Hybrid procedures for patients with critical limb ischemia and severe common femoral artery atherosclerosis, Ann Vasc Surg, 25, 1063, 10.1016/j.avsg.2011.07.010
Crawford, 2014, A modern series of acute aortic occlusion, J Vasc Surg, 59, 1044, 10.1016/j.jvs.2013.10.080
Lammer, 2015, Sustained benefit at 2 years for covered stents versus bare-metal stents in long SFA lesions: the VIASTAR trial, Cardiovasc Intervent Radiol, 38, 25, 10.1007/s00270-014-1024-9
Laird, 2012, Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial, J Endovasc Ther, 19, 1, 10.1583/11-3627.1
Schillinger, 2007, Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting, Circulation, 115, 2745, 10.1161/CIRCULATIONAHA.107.688341
Liistro, 2013, Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery), JACC Cardiovasc Interv, 6, 1295, 10.1016/j.jcin.2013.07.010
Rosenfield, 2015, Trial of a paclitaxel-coated balloon for femoropopliteal artery disease, N Engl J Med, 373, 145, 10.1056/NEJMoa1406235
Tepe, 2015, Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial, Circulation, 131, 495, 10.1161/CIRCULATIONAHA.114.011004
Tepe, 2008, Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg, N Engl J Med, 358, 689, 10.1056/NEJMoa0706356
Werk, 2012, Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial, Circ Cardiovasc Interv, 5, 831, 10.1161/CIRCINTERVENTIONS.112.971630
Geraghty, 2013, Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease, J Vasc Surg, 58, 386, 10.1016/j.jvs.2013.01.050
Scheinert, 2013, Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal artery stent registry, JACC Cardiovasc Interv, 6, 65, 10.1016/j.jcin.2012.09.011
Tosaka, 2012, Classification and clinical impact of restenosis after femoropopliteal stenting, J Am Coll Cardiol, 59, 16, 10.1016/j.jacc.2011.09.036
Bradbury, 2010, Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making, J Vasc Surg, 51, 52s, 10.1016/j.jvs.2010.01.077
Arvela, 2012, Outcome of infrainguinal single-segment great saphenous vein bypass for critical limb ischemia is superior to alternative autologous vein bypass, especially in patients with high operative risk, Ann Vasc Surg, 26, 396, 10.1016/j.avsg.2011.08.013
Brass, 2006, Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia, J Vasc Surg, 43, 752, 10.1016/j.jvs.2005.11.041
Mills, 2014, The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI), J Vasc Surg, 59, 220, 10.1016/j.jvs.2013.08.003
Singh, 2014, Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty, Vasc Med, 19, 307, 10.1177/1358863X14538330
Takahara, 2010, The influence of glycemic control on the prognosis of Japanese patients undergoing percutaneous transluminal angioplasty for critical limb ischemia, Diabetes Care, 33, 2538, 10.2337/dc10-0939
Dominguez, 2015, Endovascular therapy for critical limb ischemia, Expert Rev Cardiovasc Ther, 13, 429, 10.1586/14779072.2015.1019472
Lumsden, 2009, Medical and endovascular management of critical limb ischemia, J Endovasc Ther, 16, 31
Manzi, 2011, Endovascular techniques for limb salvage in diabetics with crural and pedal disease, J Cardiovasc Surg (Torino), 52, 485
Adam, 2005, Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial, Lancet, 366, 1925, 10.1016/S0140-6736(05)67704-5
Zeller, 2014, Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial, J Am Coll Cardiol, 64, 1568, 10.1016/j.jacc.2014.06.1198
Menard, 2014, The BEST-CLI trial: a multidisciplinary effort to assess whether surgical or endovascular therapy is better for patients with critical limb ischemia, Semin Vasc Surg, 27, 82, 10.1053/j.semvascsurg.2015.01.003
Popplewell, 2016, Bypass versus angio plasty in severe ischaemia of the leg - 2 (BASIL-2) trial: study protocol for a randomised controlled trial, Trials, 17, 11, 10.1186/s13063-015-1114-2
Teraa, 2016, Critical limb ischemia: current trends and future directions, J Am Heart Assoc, 5, e002938, 10.1161/JAHA.115.002938
Belch, 2011, Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia, Lancet, 377, 1929, 10.1016/S0140-6736(11)60394-2
Moazzami, 2014, Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia, Cochrane Database Syst Rev, 12
Peeters Weem, 2015, Bone marrow derived cell therapy in critical limb ischemia: a meta-analysis of randomized placebo controlled trials, Eur J Vasc Endovasc Surg, 50, 775, 10.1016/j.ejvs.2015.08.018
Sobel, 2008, Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition), Chest, 133, 815s, 10.1378/chest.08-0686
Rutherford, 1997, Recommended standards for reports dealing with lower extremity ischemia: revised version, J Vasc Surg, 26, 517, 10.1016/S0741-5214(97)70045-4
Berridge, 2002, Surgery versus thrombolysis for acute limb ischaemia: initial management, Cochrane Database Syst Rev, 3, 10.1002/14651858.CD002784
Savji, 2013, Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects, J Am Coll Cardiol, 61, 1736, 10.1016/j.jacc.2013.01.054
Aboyans, 2016, Renal Artery stenosis in patients with peripheral artery disease: prevalence, risk factors and long-term prognosis, Eur J Vasc Endovasc Surg, 53, 380, 10.1016/j.ejvs.2016.10.029
Aboyans, 2015, Polyvascular disease: definition, epidemiology, relevance, 4779
Ahmed, 2009, Prevalence of significant asymptomatic carotid artery disease in patients with peripheral vascular disease: a meta-analysis, Eur J Vasc Endovasc Surg, 37, 262, 10.1016/j.ejvs.2008.10.017
Durand, 2004, Mandatory versus selective preoperative carotid screening: a retrospective analysis, Ann Thorac Surg, 78, 159, 10.1016/j.athoracsur.2004.02.024
Fowkes, 2006, Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease: results of the international AGATHA study, Eur Heart J, 27, 1861, 10.1093/eurheartj/ehl114
Mukherjee, 2007, Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events), Am J Cardiol, 100, 1, 10.1016/j.amjcard.2007.02.046
Naylor, 2002, Carotid artery disease and stroke during coronary artery bypass: a critical review of the literature, Eur J Vasc Endovasc Surg, 23, 283, 10.1053/ejvs.2002.1609
Steinvil, 2011, Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease, J Am Coll Cardiol, 57, 779, 10.1016/j.jacc.2010.09.047
Subherwal, 2012, Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction, Circ Cardiovasc Qual Outcomes, 5, 541, 10.1161/CIRCOUTCOMES.111.964379
Collet JP, Cayla G, Ennezat PV, Leclercq F, Cuisset T, Elhadad S, et al; for the AMERICA Investigators. Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: the randomized AMERICA Study [submitted].
Lin, 2016, Clinical utility of carotid duplex ultrasound prior to cardiac surgery, J Vasc Surg, 63, 710, 10.1016/j.jvs.2015.10.008
Masabni, 2015, Does preoperative carotid stenosis screening reduce perioperative stroke in patients undergoing coronary artery bypass grafting?, J Thorac Cardiovasc Surg, 149, 1253, 10.1016/j.jtcvs.2015.02.003
Naylor, 2011, Stroke after cardiac surgery and its association with asymptomatic carotid disease: an updated systematic review and meta-analysis, Eur J Vasc Endovasc Surg, 41, 607, 10.1016/j.ejvs.2011.02.016
Schoof, 2007, Impaired cerebral autoregulation distal to carotid stenosis/occlusion is associated with increased risk of stroke at cardiac surgery with cardiopulmonary bypass, J Thorac Cardiovasc Surg, 134, 690, 10.1016/j.jtcvs.2007.03.018
Stamou, 2001, Stroke after coronary artery bypass: incidence, predictors, and clinical outcome, Stroke, 32, 1508, 10.1161/01.STR.32.7.1508
Naylor, 2008, Delay may reduce procedural risk, but at what price to the patient?, Eur J Vasc Endovasc Surg, 35, 383, 10.1016/j.ejvs.2008.01.002
Lamy, 2012, Off-pump or on-pump coronary-artery bypass grafting at 30 days, N Engl J Med, 366, 1489, 10.1056/NEJMoa1200388
Illuminati, 2011, Short-term results of a randomized trial examining timing of carotid endarterectomy in patients with severe asymptomatic unilateral carotid stenosis undergoing coronary artery bypass grafting, J Vasc Surg, 54, 993, 10.1016/j.jvs.2011.03.284
Randall, 2006, Is there any benefit from staged carotid and coronary revascularization using carotid stents? A single-center experience highlights the need for a randomized controlled trial, Stroke, 37, 435, 10.1161/01.STR.0000198876.32450.a7
Van der Heyden, 2007, Staged carotid angioplasty and stenting followed by cardiac surgery in patients with severe asymptomatic carotid artery stenosis: early and long-term results, Circulation, 116, 2036, 10.1161/CIRCULATIONAHA.106.658625
Versaci, 2007, Sequential hybrid carotid and coronary artery revascularization: immediate and mid-term results, Ann Thorac Surg, 84, 1508, 10.1016/j.athoracsur.2007.05.048
Chiariello, 2015, Simultaneous carotid artery stenting and heart surgery: expanded experience of hybrid surgical procedures, Ann Thorac Surg, 99, 1291, 10.1016/j.athoracsur.2014.11.043
Shishehbor, 2013, A direct comparison of early and late outcomes with three approaches to carotid revascularization and open heart surgery, J Am Coll Cardiol, 62, 1948, 10.1016/j.jacc.2013.03.094
Aboyans, 2009, Indications for carotid screening in patients with coronary artery disease, Presse Med, 38, 977, 10.1016/j.lpm.2009.02.015
Naylor, 2003, A systematic review of outcomes following staged and synchronous carotid endarterectomy and coronary artery bypass, Eur J Vasc Endovasc Surg, 25, 380, 10.1053/ejvs.2002.1895
Paraskevas, 2017, Carotid stenting prior to coronary bypass surgery: an updated systematic review and meta-analysis, Eur J Vasc Endovasc Surg, 53, 309, 10.1016/j.ejvs.2016.12.019
Imori, 2014, Co-existence of carotid artery disease, renal artery stenosis, and lower extremity peripheral arterial disease in patients with coronary artery disease, Am J Cardiol, 113, 30, 10.1016/j.amjcard.2013.09.015
Kim, 2013, Peripheral artery disease in Korean patients undergoing percutaneous coronary intervention: prevalence and association with coronary artery disease severity, J Korean Med Sci, 28, 87, 10.3346/jkms.2013.28.1.87
Hussein, 2011, Peripheral arterial disease and progression of coronary atherosclerosis, J Am Coll Cardiol, 57, 1220, 10.1016/j.jacc.2010.10.034
Eagle, 1994, Long-term survival in patients with coronary artery disease: importance of peripheral vascular disease. The Coronary Artery Surgery Study (CASS) Investigators, J Am Coll Cardiol, 23, 1091, 10.1016/0735-1097(94)90596-7
Grenon, 2013, Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study, Vasc Med, 18, 176, 10.1177/1358863X13493825
Saw, 2006, The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials, J Am Coll Cardiol, 48, 1567, 10.1016/j.jacc.2006.03.067
Aboyans, 2005, Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting, J Am Coll Cardiol, 46, 815, 10.1016/j.jacc.2005.05.066
Rihal, 1999, Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigation, Circulation, 100, 171, 10.1161/01.CIR.100.2.171
Hlatky, 2013, Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study, Ann Intern Med, 158, 727, 10.7326/0003-4819-158-10-201305210-00639
Farooq, 2013, Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II, Lancet, 381, 639, 10.1016/S0140-6736(13)60108-7
Dencker, 2016, Major femoral vascular access complications after coronary diagnostic and interventional procedures: a Danish register study, Int J Cardiol, 202, 604, 10.1016/j.ijcard.2015.09.018
Neufang, 2014, Outcomes of complex femorodistal sequential autologous vein and biologic prosthesis composite bypass grafts, J Vasc Surg, 60, 1543, 10.1016/j.jvs.2014.07.103
Spronk, 2009, Invasive treatment of claudication is indicated for patients unable to adequately ambulate during cardiac rehabilitation, J Vasc Surg, 49, 1217, 10.1016/j.jvs.2008.11.066
Aboyans, 2005, A predictive model for screening cerebrovascular disease in patient undergoing coronary artery bypass grafting, Interact Cardiovasc Thorac Surg, 4, 90, 10.1510/icvts.2004.092262
Valgimigli, 2015, Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial, Lancet, 385, 2465, 10.1016/S0140-6736(15)60292-6
Jones, 2011, Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION), Am J Cardiol, 108, 380, 10.1016/j.amjcard.2011.03.057
Inglis, 2013, Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT, Int J Cardiol, 168, 1094, 10.1016/j.ijcard.2012.11.033
Nakamura, 2015, Impact of peripheral artery disease on prognosis in hospitalized heart failure patients, Circ J, 79, 785, 10.1253/circj.CJ-14-1280
van Straten, 2010, Peripheral vascular disease as a predictor of survival after coronary artery bypass grafting: comparison with a matched general population, Ann Thorac Surg, 89, 414, 10.1016/j.athoracsur.2009.11.036
Calvet, 2010, Prevalence of asymptomatic coronary artery disease in ischemic stroke patients: the PRECORIS study, Circulation, 121, 1623, 10.1161/CIRCULATIONAHA.109.906958
Hofmann, 2005, Coronary angiography in patients undergoing carotid artery stenting shows a high incidence of significant coronary artery disease, Heart, 91, 1438, 10.1136/hrt.2004.050906
Illuminati, 2010, Systematic preoperative coronary angiography and stenting improves postoperative results of carotid endarterectomy in patients with asymptomatic coronary artery disease: a randomised controlled trial, Eur J Vasc Endovasc Surg, 39, 139, 10.1016/j.ejvs.2009.11.015
Illuminati, 2015, Long-term results of a randomized controlled trial analyzing the role of systematic pre-operative coronary angiography before elective carotid endarterectomy in patients with asymptomatic coronary artery disease, Eur J Vasc Endovasc Surg, 49, 366, 10.1016/j.ejvs.2014.12.030
Vidakovic, 2009, The prevalence of polyvascular disease in patients referred for peripheral arterial disease, Eur J Vasc Endovasc Surg, 38, 435, 10.1016/j.ejvs.2009.05.006
Hur, 2012, Frequency of coronary artery disease in patients undergoing peripheral artery disease surgery, Am J Cardiol, 110, 736, 10.1016/j.amjcard.2012.04.059
Ishihara, 2013, Severity of coronary artery disease affects prognosis of patients with peripheral artery disease, Angiology, 64, 417, 10.1177/0003319712452627
Bhatt, 2009, Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes, Eur Heart J, 30, 1195, 10.1093/eurheartj/ehp099
Montalescot, 2013, 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology, Eur Heart J, 34, 2949, 10.1093/eurheartj/eht296
Sirimarco, 2013, Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosis, Stroke, 44, 373, 10.1161/STROKEAHA.112.673129
Amighi, 2009, Renal artery stenosis predicts adverse cardiovascular and renal outcome in patients with peripheral artery disease, Eur J Clin Invest, 39, 784, 10.1111/j.1365-2362.2009.02180.x
Rauchhaus, 2000, Plasma cytokine parameters and mortality in patients with chronic heart failure, Circulation, 102, 3060, 10.1161/01.CIR.102.25.3060
Kahan, 2012, The importance of myocardial fibrosis in hypertensive heart disease, J Hypertens, 30, 685, 10.1097/HJH.0b013e328350e5db
O'Rourke, 2010, The Cardiovascular Continuum extended: aging effects on the aorta and microvasculature, Vasc Med, 15, 461, 10.1177/1358863X10382946
Duscha, 2002, Deconditioning fails to explain peripheral skeletal muscle alterations in men with chronic heart failure, J Am Coll Cardiol, 39, 1170, 10.1016/S0735-1097(02)01740-0
Mancini, 1992, Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure, Circulation, 85, 1364, 10.1161/01.CIR.85.4.1364
Hedberg, 2014, Left ventricular systolic dysfunction in outpatients with peripheral atherosclerotic vascular disease: prevalence and association with location of arterial disease, Eur J Heart Fail, 16, 625, 10.1002/ejhf.95
Yamasaki, 2013, Presence of diastolic dysfunction in patients with peripheral artery disease, Angiology, 64, 540, 10.1177/0003319713476135
Meltzer, 2012, Heart failure is associated with reduced patency after endovascular intervention for symptomatic peripheral arterial disease, J Vasc Surg, 55, 353, 10.1016/j.jvs.2011.08.016
Inglis, 2013, Peripheral arterial disease and chronic heart failure: a dangerous mix, Heart Fail Rev, 18, 457, 10.1007/s10741-012-9331-1
Inglis, 2010, Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA), Eur J Heart Fail, 12, 698, 10.1093/eurjhf/hfq070
Ahmed, 2010, Effects of peripheral arterial disease on outcomes in advanced chronic systolic heart failure: a propensity-matched study, Circ Heart Fail, 3, 118, 10.1161/CIRCHEARTFAILURE.109.866558
Go, 2001, Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study, JAMA, 285, 2370, 10.1001/jama.285.18.2370
Griffin, 2016, Peripheral arterial disease is associated with an increased risk of atrial fibrillation in the elderly, Europace, 18, 794, 10.1093/europace/euv369
Aboyans, 2014, Ankle-brachial index in patients with nonvalvular atrial fibrillation, J Am Coll Cardiol, 63, 1456, 10.1016/j.jacc.2013.09.071
Gallego, 2012, Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation, Eur J Clin Invest, 42, 1302, 10.1111/eci.12004
O'Neal, 2014, Peripheral arterial disease and risk of atrial fibrillation and stroke: the Multi-Ethnic Study of Atherosclerosis, J Am Heart Assoc, 3, e001270, 10.1161/JAHA.114.001270
Wasmer, 2015, Atrial fibrillation is a risk marker for worse in-hospital and long-term outcome in patients with peripheral artery disease, Int J Cardiol, 199, 223, 10.1016/j.ijcard.2015.06.094
euroSCORE interactive calculator. http://www.euroscore.org/calc.html.
Gilard, 2012, Registry of transcatheter aortic-valve implantation in high-risk patients, N Engl J Med, 366, 1705, 10.1056/NEJMoa1114705
Leon, 2010, Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery, N Engl J Med, 363, 1597, 10.1056/NEJMoa1008232
Skelding, 2016, Transcatheter aortic valve replacement versus surgery in women at high risk for surgical aortic valve replacement (from the CoreValve US High Risk Pivotal Trial), Am J Cardiol, 118, 560, 10.1016/j.amjcard.2016.05.051
Aronow, 2007, Peripheral arterial disease in the elderly, Clin Interv Aging, 2, 645, 10.2147/CIA.S2412
Adams, 2014, Transcatheter aortic-valve replacement with a self-expanding prosthesis, N Engl J Med, 371, 967, 10.1056/NEJMc1408396
Smith, 2011, Transcatheter versus surgical aortic-valve replacement in high-risk patients, N Engl J Med, 364, 2187, 10.1056/NEJMoa1103510
Sinning, 2012, The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions Registry, Am Heart J, 164, 102, 10.1016/j.ahj.2012.04.016
Erdogan, 2006, In which patients should sheathless IABP be used? An analysis of vascular complications in 1211 cases, J Card Surg, 21, 342, 10.1111/j.1540-8191.2006.00268.x